Dopamine receptor whose activity is mediated by G proteins which inhibit adenylyl cyclase (PubMed:21645528). Positively regulates postnatal regression of retinal hyaloid vessels by means of suppression of VEGFR2/KDR exercise, downstream of OPN5 (By similarity). FDA thinks this being the most precise process for identifying the contents of OTC solu